Introduction

Malaria remains one of the major health threats globally. Of the estimated 263 million malaria cases recorded worldwide in 2023, 94% (246 million cases) occurred in Africa. Five African countries; Nigeria (25.9%), the Democratic Republic of the Congo (12.6%), Uganda (4.8%), Ethiopia (3.6%), and Mozambique (3.5%), together accounted for 52% of the global malaria burden (1). Similarly, 95% of the estimated 597,000 global malaria deaths in 2023 were recorded in the WHO African Region. Four African countries accounted for more than 50% of these deaths, with 39.3% of all global malaria deaths in children under five years occurred in Nigeria (1, 2). Although reasons advanced for the upwards trends in malaria cases and deaths included lack of funding and investment, particularly in high-burden African countries, the main reason might not be far from poverty and poor economic condition. Not only are the major artemisinin combination therapies (ACTs) very costly and beyond the reach of the poor populace, but many people are also financially handicapped to access health facilities for treatment. Quite worrisome is the report of artemisinin partial resistance confirmed in Eritrea, Rwanda, Uganda and Tanzania, and suspected in Ethiopia, Sudan, Namibia and Zambia (1). The emerging piperaquine resistance that has emerged in some South American countries (1), which will likely spread and reduce the efficacy of dihydroartemisinin–piperaquine coupled with the inability of the currently introduced vaccines to provide lasting efficacy and durable protection, poses a serious threat to the control of malaria menace and deadly consequences.

In spite of significant gains achieved in the management of malaria over the past years, the above 2023 malaria data indicate that malaria is a serious threat to lives in Africa, and Nigeria in particular sequel to emergence of partial resistance to artemisinin in some Arican countries (1). Therefore, instigating researchers to search for safe and cost-effective treatments. Medicinal plants provide the reservoirs for potential efficacious antimalarial drugs including the front-line drug, artemisinin and others. Previously we have investigated a number of medicinal plants in Nigeria in vitro and in vivo (3-8) for the development of potential treatment of malaria.

Telfairia occidentalis Hook, is a fluted pumpkin of the Cucurbitaceae family widely consumed as food in Nigeria, especially in the Niger-Delta region and the Eastern part of the country (9). It is a widely consumed vegetable across Nigeria, particularly in the Niger-Delta and Eastern regions, where various meals are prepared from its leaves, stem, and seeds (10). The seeds are very nutritious and are eaten roasted or boiled. The seed has history of being effective in the treatment and prevention of prostrate disorders. The seed extract has been reported to exert antidiabetic (11) cellular antioxidant, immunodulatory, anticancer, antiinflammatory (12), antiplasmodial (13), antioxidant (14), analgesic (14, 15), genotoxic and cytotoxic (16), in vivo inhibitory effect alpha amylase and alpha glucosidase (17), antiulcer (18) and antiprostatic (19) activities. Phytochemical studies of the extract have shown the presence of alkaloid, flavonoid, tannins, terpenes, saponin, and cardiac glycosides (20). Some terpenoids and fatty acid esters including 16-octadecenoic acid methyl ester; octadecanoic acid, terpinen-4-ol; trans-β-ocimene and borneol have previously been reported in the seed extract (12). While HPLC characterisation of the seed extract and fractions revealed the presence of eleven flavonoids; kaempferol, catechin, epicatechin, anthocyanidin, naringenin, flavonones, flavones, rutin, naringin, and resveratol in the seed extract and fractions with butanol fraction having the highest concentration. Also, alkaloids such as ribalinidine, ammodendrine, spartein and lunamarin were found in the seed extract and fractions (20). Although earlier studies (13, 20), had reported on antiplasmodial potential of the T. occidentalis crude seed extract against P. berghei infection in mice, investigation of antimalarial potentials of its solvent fractions to identify the most active fraction has not been carried out. The present study was designed to evaluate the activities of seed extract and fractions of T. occidentalis in Plasmodium berghei-infected mice and to analyse the active antiplasmodial fraction for possible involvement of volatile phytochemical compounds in the antimalarial activities of the seed extract and fractions using GCMS.

Materials and Methods

Plant Collection and Extraction

Fresh seeds of Telfairia occidentalis were purchased from Itam market in Itu L. G. A, Akwa Ibom State, Nigeria, in June, 2023. The seeds were previously identified and authenticated by a taxonomist in the Department of Botany and Ecological Studies, University of Uyo, Uyo, Nigeria. Herbarium specimens (UUPH 1(b)) were deposited at Department of Pharmacognosy and Natural Medicine Herbarium, University of Uyo. The fresh seeds of the plant were dried on laboratory table for 2 weeks and reduced to powder. The seeds powder (1 kg) was macerated in 50% ethanol (Sigma-Aldrich, USA) (5000 mL) for 72 h, while the remaining part (2 kg) was successively and gradiently macerated for 72 h in 5000 mL of each of, n-hexane, dichloromethane, ethyl acetate and methanol (Sigma-Aldrich, USA) respectively, along their polarity to give the corresponding gradient fractions for each solvent. The liquid filtrate of crude extract and solvent fractions were concentrated and evaporated to dryness in vacuo 40 °C using a rotary evaporator (Yamato scientific co. Ltd, USA). The various yields were calculated and the extract/solvent fractions were stored in a refrigerator at -4 °C, until used for the proposed experiments.

["Equation", "Equation 1 | where parasitemia (%) is the percentage of infected erythrocytes relative to the total erythrocytes counted.", "93%", "150", "2", "\text{Parasitemia (\%)} = \frac{\text{Total number of parasitised RBCs}}{\text{Total number of RBCs}} \times 100"]

Microorganism

Chloroquine-sensitive strain of Plasmodium berghei (ANKA strain) was obtained from the National Institute of Medical Research (NIMR), Yaba Lagos, Nigeria and maintained by subpassage of blood from infected to healthy mouse once every 7-8 days.

Parasite Inoculation

Each mouse used in the experiment was inoculated intraperitoneally with 0.2 mL of infected blood containing about 1 x 10⁷P. berghei parasitized erythrocytes collected from an infected-mice with 20-30% parasitemia. The inoculum consisted of 5 x 10⁷P. berghei infected erythrocytes per milliliter prepared by determining both the percentage parasitemia and the erythrocytes count of the donor mouse and diluting the blood with isotonic saline in proportions indicated by both determinations (7, 21). Parasitemia was monitored by standard methods; thin blood smears were made on glass slides, fixed using methanol, and stained using Giemsa stain (Sigma, USA), and parasitemia was counted using a microscope (Nikon, UK) and was calculated as a percentage of infected red blood cells (RBCs) relative to the total number of cells in a microscopic field at ×100 magnification according to the formula of Peters and Robinson, 1992 (22) as shown in Equation 1.

Experimental Animals

Swiss albino mice (18-25 g), male and female, used in the study were obtained from the University of Uyo’s animal house. They were kept in standard plastic cages in a well-ventilated room and left to acclimatized for a period of 10 days before the experiments. The mice were fed on standard pelleted diet and water ad libitum, kept under ambient temperature (28 ± 2 °C) and illuminated environment of 12:12 h dark/light cycle. The care and use of animals were conducted in accordance with the National Institute of Health Guide for the Care and Use of laboratory Animals (23). Prior ethical approval for the study was obtained from the University of Uyo’s Animal Ethics Committee (UU/CHS/IHREC/23/VOL.1/36).

Drug Administration

In this study, extract and fractions dissolved in 12% Tween 80, chloroquine and pyrimethamine (Sigma, USA) dissolved in distilled water were administered orally with the aid of a stainless metallic feeding cannula.

Evaluation of the In Vivo Antimalarial Activities of Crude Extracts and Solvent Fractions of Telfairia occidentalis Seed:

Evaluation of Suppressive Activities of the Crude Extract and Solvent Fractions of T. occidentalis Seed (4-Day Test)

This test was used to evaluate the schizontocidal activity of the crude extract and solvent fractions as well as chloroquine against early P. berghei infection in mice. This was done as described previously (24, 25). Forty-five mice were randomly divided into nine groups of five (5) mice each. On the first day (D₀), the 45 mice were infected with the parasite and randomly divided into various groups based on their body weights. They were administered the crude extract, gradient fractions, chloroquine and distilled water. Based on the previously established LD₅₀ of 3460 mg/kg of the seed extract (25), the administered doses were chosen as fractions (1/6.25, 1/12.5 and 1/25) of the LD₅₀and the the mice in groups 1-3 were given 138 mg/kg, 276 mg/kg and 553 mg/kg of crude extract respectively, while groups 4, 5, 6, and 7 were administered 276 mg/kg of n-hexane, dichloromethane, ethyl acetate, and methanol solvent fractions respectively. Group 8 was given 5 mg/kg of chloroquine (positive control) and group 9 was given 10 mL/kg of distilled water (negative control) for four consecutive days (D₀-D₃) between 8am to 9am. On the fifth day (D₄), thin films were made from the tail blood. The films were stained with Giemsa stain to reveal parasitized erythrocytes counted out of 500 in a random field of the microscope. The average suppression of parasitemia was calculated (24) as follows: (average % parasitemia positive control – average % parasitemia negative control) / (average % parasitemia negative control). The mean survival time of the mice in each treatment group was determined over a period of 29 days (D₀-D₂₈).

Evaluation of Prophylactic Activities of the Crude Extract and Solvent Fractions of Telfairia occidentalis Seed

This was evaluated using a standard method described previously (26, 7). The mice were randomly divided into nine groups of five mice per group. Groups 1-3 were given 138, 276 and 553 mg/kg of crude extract respectively, groups 4, 5, 6, and 7 were given 276 mg/kg of n-hexane, ethyl acetate, dichloromethane, and methanol solvent fractions respectively, group 8 was given 1.2 mg/kg of pyrimethamine (positive control) and group 9 was given 10 mL/kg of distilled water (negative control). Administration of the extract and fractions continued for three consecutive days (D₀-D₂). On the fourth day (D₃), the mice were inoculated with P. berghei. The parasitemia level was assessed by blood smears 72 h later. The mean survival time of the animals was calculated over a period of 29 days.

Evaluation of the Curative Activities of the Crude Extract and Solvent Fractions of Telfairia occidentalis Seed

This test was done according to standard method (27) and used to evaluate the schizontocidal activity of the extract, fractions and chloroquine in established plasmodial infection. P. berghei was injected intraperitoneally into forty five (45) mice on the first day (D₀). Seventy two hours later (D₃), the mice were divided into nine groups of five mice per group. Groups 1-3 were given different doses of extract, 138, 276 and 553 mg/kg respectively, groups 4-7 were given 276 mg/kg of n-hexane, ethyl acetate, dichloromethane, and methanol solvent fractions respectively, group 8 was given 5 mg/kg chloroquine (positive control) and group 9 was given 10 mL/kg distilled water (negative control). The crude extract, gradient fractions and chloroquine were administered once daily for 5 days. Giemsa stained thin smears were prepared from tail blood samples collected on each day of treatment to monitor the parasitemia level. Rectal temperatures of the mice were taken on days 0, 3, 5, and 7. The mean survival time (MST) of the mice in each group was determined over a period of 29 days (D₀-D₂₈).

Gass Chromatography Mass-Spectrometry Analysis

Gas chromatography-mass spectrometry (GC-MS) data of the active solvent fraction (methanol) were recorded on an An Agilent 6890N gas chromatography equipped with an autosampler connected to an Agilent Mass Spectrophotometric Detector. One microliter of the sample was injected in the pulsed spitless mode onto a 30 m x 0.25 mm ID DB 5MS coated fused silica column with a film thickness of 0.15 micrometer. Helium gas was used as a carrier gas, and the column head pressure was maintained at 20 psi to give a constant of 1ml/min. Other operating conditions were preset. The column temperature was initially held at 55 °C for 0.4min, increased to 200 °C at a rate of 25 °C/mins, then to 280 °C at a rate of 8 °C/mins and to a final temperature of 300 °C at a rate of 25 °C/mins, held for 2 mins. The identification time was based on retention time. Components with lower retention time elute first before the ones of higher retention time. The fractions were directly injected in n-hexane as described previously (28). The phytochemicals were identified by comparison of spectra in the NIST 2011 database.

Statistical Analysis

Data collected were analyzed using one way analysis of variance (ANOVA) followed by Tukey’s multiple comparison post-test (Graph pad prism software Inc. La Jolla, CA, USA). Values were expressed as mean ± SEM and significance relative to control were considered at p < 0.05.

Results

Yields of Crude Extract and Solvent Fractions

The percentage yields of the crude extract and solvent fractions were; crude 21.03%, n-hexane 1.6%, DCM 2.82%, ethyl acetate 1.04%, methanol 2.1%.

Suppressive Activities of Ethanol Crude Extract and Solvent Fractions of Telfairia occidentalis Seed

The seed extract and its solvent fractions exerted dose-dependent reductions in parasitemia of the treated mice in various groups. The reductions were statistically significant (p < 0.05) at all doses administered when compared to the negative control. The methanol solvent fraction exerted the highest suppressive effect (65.67%) with MST of 18.33 ± 3.71 days followed by n-hexane fraction (43.27%) with MST of 12.00 ± 1.00 days. Although the extracts’ treatments resulted in considerable prolongation of the mean survival time (m.s.t) of the infected mice, these were only significant (p < 0.01-0.001) in the groups treated with the middle and high doses of the crude extract (276 and 553 mg/kg), ethyl acetate and methanol solvent fractions, when compared to the negative control (Table 1).

Prophylactic/Repository Activities of Ethanol Crude Extract and Gradient Extractof Telfairia occidentalis Seed

The seed crude extract exerted dose-dependent reductions of parasitemia in the treated groups with the highest dose (553 mg/kg) producing the highest chemosuppression of 55.39% and m.s.t value of 17.66 ± 2.18 days. These reductions were statistically significant relative to the negative control (p < 0.001). The dichloromethane fraction["Table", "Table 1. Suppressive activities of seed extract and fractions of Telfairia occidentalis during early Plasmodium berghei infection in mice.", "8pt", "1", "false"]["Table", "Table 2. Prophylactic activities of seed extract and fractions of Telfairia occidentalis.", "8pt", "1", "false"]caused a chemosuppressive effect of 46.55% with MST value of 14.33 ± 0.33% followed by ethyl acetate fraction with chemosuppressive activity of 39.21% and m.s.t value of 13.33 ± 0.66 days which was not significant (p > 0.05) when compared with negative control. The standard drug, pyrimethamine, 1.2 mg/kg exhibited a prophylactic activity of 81.82% (Table 2).

Treatment	Dose (mg/kg)	Parasitaemia	Chemosuppression (%)	MST
Control	-	30.39 ± 1.62	-	7.00 ± 0.57
Extract	138	20.56 ± 1.04^c	32.34	9.66 ± 0.88
	276	15.96 ± 0.95^c	47.48	17.00 ± 2.08^b
	553	13.35 ± 1.22^c	56.07	18.33 ± 1.45^c
n-hexane	276	17.24 ± 0.66^c	43.27	12.00 ± 1.00
Dichloromethane	276	18.03 ± 0.56^c	40.67	12.00 ± 1.00
Ethyl acetate	276	19.93 ± 1.62^c	34.41	11.33 ± 1.45
Methanol	276	10.43 ± 2.67^c	65.67	18.66 ± 3.71^c
Chloroquine	5	5.04 ± 0.61^c	77.94	29.50 ± 0.34^c
Note: Values are expressed as mean ± SEM. Significant relative to control. ^ap < 0.05; ^bp < 0.01; ^cp < 0.001. n = 5.

Treatment	Dose (mg/kg)	Parasitaemia	Chemosuppression (%)	MST
Control	-	25.22 ± 2.14	-	8.00 ± 0.57
Extract	138	20.64 ± 1.48	18.16	11.33 ± 0.88
	276	16.33 ± 1.32^c	35.24	12.66 ± 2.96
	553	11.25 ± 1.54^c	55.39	17.66 ± 2.18^b
n-hexane	276	22.44 ± 1.20	11.02	10.00 ± 1.52
Dichloromethane	276	13.48 ± 0.45^c	46.55	14.33 ± 0.33
Ethyl acetate	276	15.33 ± 0.82^c	39.21	13.33 ± 0.66
Methanol	276	21.33 ± 0.93	15.42	11.66 ± 1.20
Pyrimethamine	1.2	4.33 ± 0.66^c	81.82	25.66 ± 1.22^c
Note: Values are expressed as mean ± SEM. Significant relative to control ^ap < 0.05; ^bp < 0.01; ^cp < 0.001. n = 5.

Antiplasmodial Effect of Ethanol Crude Extract and Fractions of Telfairia occidentalis on Established Infection

There were progressive dose-dependent reductions of parasitemia in all the extract-treated groups relative to negative control. These reductions were statistically significant relative to the negative control (p < 0.001; Figure 1). The methanol fraction had the highest activity with chemosuppressive effect of 77.48% on day 7, this was lower compared with that of the standard, chloroquine, 93.17%. The seed extract demonstrated significant (p < 0.05-0.001) prolongation in the mean survival time of the animals. The groups treated with methanol fraction had a longer mean survival time, 18.00 ± 1.15 days followed by those of crude extract (553 mg/kg) treated mice, 15.66 ± 1.45 days. These were less than that of the standard drug, chloroquine (29.83 ± 0.16 days; Figure 2).

Effect of Seed Extract/Fractions on Rectal Temperatures of Infected Mice

Administration of the seed extract and fractions of T. occidentalis as well as chloroquine to Plasmodium berghei-infected mice in curative test did not cause any significant difference (p > 0.05) in the rectal temperatures of the treated mice when compared with that of controls (Table 3).

GC-MS Analysis

GC–MS analysis of the methanol fraction revealed the presence of pharmacologically active compounds such as hexanoic acid, 5,6-dibromo-6-[p-chlorophenyl]-2,4-dioxo-, ethyl ester; octanoic acid; palmitic acid, 9-hexadecenyl ester (Z)-; oleic acid, 2-(1-octadecenyloxy)ethyl ester (E)-; 9,12-octadecadienoic acid (Z,Z)-, 2-[(trimethylsilyl)oxy]-1-[[(trimethylsilyl)oxy]methyl]ethyl ester; α-carotene, 7,8-dihydro-3,3',19-trihydroxy-8-oxo-, triacetate, all-trans-; and eicosanoic acid, octadecyl ester, among others (Table 4; Figure 3).

Discussion

The seeds of T. occidentalis are used locally as food and to treat various diseases such as malaria, diabetes, fever, inflammatory diseases and pain among others. This work was designed to confirm and authenticate the antimalarial potentials of the seed extract and solvent fractions of T. occidentalis in order to provide scientific basis for its usage["Figure", "https://etflin.com/file/figure/20260223043739469172613.jpeg", "Figure 1. Effect of seed extract and fractions of T. occidentalis on established Plasmodium berghei infection in mice.", "", "100%", "2"]["Figure", "https://etflin.com/file/figure/20260223043739100695510.jpeg", "Figure 2. Effect of seed extract and fractions of Telfairia occidentalis on mean survival time (MST) of Plasmodium berghei-infected mice during established infection. Values are expressed as mean ± SEM. Significant relative to control at *p < 0.05; **p < 0.01; ***p < 0.001. n = 5.", "", "100%", "2"]in traditional medicine. The seed extract and solvent fractions of T. occidentalis were investigated for antimalarial activity against rodent malaria parasite, P. berghei infection in mice using standard in vivo models. The extract/fractions significantly reduced the parasitemia in suppressive, prophylactic and curative models in a dose-dependent fashion with methanol fraction exerting the highest suppression and curative activities, while DCM fraction exerted prominent prophylactic activity confirming the antimalarial potential of the seed extract.

The extract and fractions also prolonged the MST of the mice in different models suggesting that they were able to offer certain degree of protection to the mice. This activity could have resulted from plasmodicidal or plasmodistatic activity of the extracts. This further confirms and validates the use of the seed decoctions as malarial remedy. The slight variation in the activities of the extract and fractions suggests the involvement of immunostimulating activity which may be due to the phytochemical constituents in these extract/solvents. Tannins and fatty acids such as linoleic acids have been reported to possess immune-stimulating properties (29, 30).

The strong suppressive activities of the extract and fractions on the development of Plasmodium berghei parasitemia as observed during in the study, suggest that the extract affect the erythrocytic stages of the parasite (31). The inability of the extract and fractions to give complete protection to the infected mice in most cases could have resulted from low doses (138 - 553 mg/kg) used, short half-life/ duration of action of the extract/fractions due to rapid biotransformation processes and subsequent elimination (31). Thus, resulting in further development and multiplication of the parasites as well as short MST of the treated mice as observed in this study. However, these results corroborate previous reports on antimalarial activities of the leaf, seed and root extracts of T. occidentalis (32, 13) where significant suppressive, prophylactic and curative activities were recorded. These results validate the use of the seed of T. occidentalis decoctions as malarial remedy. In this investigation, in vitro study, isolation and characterisation of pure compounds from the active fraction could not be carried out to confirm the activities observed in the in vivo study.

Okokon et al. (12) reported the presence of polyunsaturated fatty acids such as hexadecanoic acid; 16-octadecenoic acid methyl ester; 9,12-octadecadienoyl chloride (Z,Z); 9-octadecadienoic acid (Z)-, 2,3-dihydroxypropyl ester; octadecanoic acid; hexadecanoic acid, 2,3-bis[(trimethylsilyl)oxy]propyl ester; linoleic acid ethyl ester; and hexadecanoic acid methyl ester, as well as monoterpenes such as α-phellandrene; α-campholene aldehyde; terpinen-4-ol; trans-β-ocimene; and borneol in the seed extract. Also, in this study, GC–MS analysis of the active antiplasmodial methanol fraction revealed the presence of polyunsaturated fatty acid compounds such as hexanoic acid, 5,6-dibromo-6-[p-chlorophenyl]-2,4-dioxo-, ethyl ester; octanoic acid; palmitic acid, 9-hexadecenyl ester (Z)-; oleic acid, 2-(1-octadecenyloxy)ethyl ester (E)-; 9,12-octadecadienoic acid (Z,Z)-, 2-[(trimethylsilyl)oxy]-1-[[(trimethylsilyl)oxy]methyl]ethyl ester; α-carotene, 7,8-dihydro-3,3',19-trihydroxy-8-oxo-, triacetate, all-trans-; and eicosanoic acid, octadecyl ester, among others (Figure 4).

Previous studies of the seed extract and fractions by HPLC indicted flavonoids as the main antiplasmodial agents and revealed the presence of eleven flavonoids; kaempferol, catechin, epicatechin, anthocyanidin, flavonones, flavones, naringenin ,rutin, naringin, and resveratol in the extract and fractions (20). Moreso, alkaloids such as spartein, ribalinidine lunamarin and ammodendrine were found to be present in high concentration in the butanol fraction of the seed extract (20). These compounds may be responsible for the observed activities of the extract and fractions. Some secondary metabolites of plants such as alkaloids, flavonoids and triterpenoids have been reported to have antiplasmodial properties (33-35). Polyunsaturated fatty acids (PUFAs) such as hexadecanoic acid, methyl ester, 9,12-octadecadienoic acid methyl ester (linoleic acid), 9,12,15-octadecatrienoic acid, methyl ester (linoleic acid), and 9-octadecenoic acid as found in the active antiplasmodial fractions in this study have been implicated in antiplasmodial activity and this activity has been reported to increase with the degree of unsaturation (36-42). Also, flavonoids in the seed extract have been shown to possess significant antiplasmodial activity against chloroquine sensitive and resistant strains of P. falciparum (43-45). Antioxidant property of flavonoids has been suggested to be responsible for its antiplasmodial activity (46, 44), as elevated free radical levels are common features of malaria disease and are implicated in severe malaria complications. Scavenging of these free radicals could be one of the mechanisms of action of this extract. Other proposed mechanisms of antiplasmodial activity for["Table", "Table 3. Effect of seed extract and fractions of T. occidentalis on rectal temperatures of mice infected with P. berghei during established infection.", "8pt", "1", "false"]["Table", "Table 4. GC-MS analysis of methanol fraction.", "8pt", "1", "false"]flavonoids are chelation of nucleic acid base pairing of the parasite (47), modulation of host immunity to tackle disease and inhibition of plasmodial enoyl-ACP reductase (FAB I enzyme) – a key regulator of type II fatty synthases (FAS-II) in P. falciparum (48, 49) and binding to parasite’s serinethreonine kinase with high affinity thereby affecting its development (50). Furthermore, terpenes and their derivatives, monoterpenes and sesquiterpenes, have been implicated in antiplasmodial activity of many plants (34, 35). Monoterpenes such as limonene, trans-β-ocimene and α-pinene found in the dichloromethane fraction of the seed extract have been implicated in endoperoxidation leading to plasmocidal activity (51).

Treatment	Dose (mg/kg)	Rectal Temperature (˚C)
Treatment	Dose (mg/kg)	D0	D3	D5	D7
Control	-	36.96 ± 0.34	37.31 ± 0.11	37.94 ± 0.32	38.27 ± 0.16
Extract	138	36.85 ± 0.23	35.33 ± 0.20	35.73 ± 0.74	36.80 ± 0.35
	276	36.98 ± 0.19	36.70 ± 0.50	37.66 ± 0.15	37.28 ± 0.15
	553	37.66 ± 0.50	36.51 ± 0.35	36.86 ± 0.24	36.95 ± 0.63
n-hexane	276	36.46 ± 0.40	36.36 ± 0.14	36.60 ± 0.40	37.40 ± 0.27
Dichloromethane	276	36.85 ± 0.39	37.30 ± 0.17	36.68 ± 0.60	37.40 ± 0.04
Ethyl acetate	276	36.46 ± 0.60	36.86 ± 0.18	36.36 ± 0.43	37.62 ± 0.52
Methanol	276	36.48 ± 0.20	36.60 ± 0.08	36.40 ± 0.40	36.76 ± 0.44
Chloroquine	5	37.20 ± 0.40	36.83 ± 0.21	37.31 ± 0.25	37.65 ± 0.21
Note: Values are expressed as mean ± SEM.

Peak	RT (min)	Compound	Peak Area%	Mol. Form	Mol. Mass (amu)
1.	4.733	Acetic acid, 1,1-dimethylethyl ester	11.812	C₆H₁₂O₂	116.083
2.	7.376	Butanoic acid, 1,1-dimethyethyl ester	59.868	C₈H₁₆O₂	144.115
3.	9.721	Propanoic acid	1.557	C₃H₆O₂	74.036
4.	10.705	Hexanoic acid, 5,6-dibromo-6-[p-chlorophenyl]-2,4-dioxo-, ethyl ester	1.352	C₁₄H₁₃Br₂ClO₄	437.886
5.	14.983	Octanoic acid	1.412	C₈H₁₆O₂	144.115
6.	15.175	Palmitic acid, 9-hexadecenyl ester, (Z)-	1.343	C₃₂H₆₂O₂	478.474
7.	15.477	Oleic acid, 2-(1-octadecenyloxy)ethyl ester, (E)-	2.015	C₃₈H₇₂O₃	576.548
8.	16.606	α-Carotene, 7,8-dihydro-3,3',19-trihydroxy-8-oxo-, triacetate, all-trans-	1.534	C₄₆H₆₂O₇	726.449
9.	19.959	Eicosanoic acid	1.891	C₂₀H₄₀O₂	312.302
10.	20.745	Eicosanoic acid, octadecyl ester	1.364	C₃₈H₇₆O₂	564.584
11.	21.391	Octanoic acid, 2-hexenyl ester, (E)	1.655	C₁₄H₂₆O₂	226.193
12.	22.648	1,3-Dioxolane-2-pentanoic acid, 2-methyl-, ethyl ester	2.198	C₁₁H₂₀O₄	216.136
13.	22.770	9,12-Octadecadienal	1.446	C₁₈H₃₂O	264.245
14.	22.816	1-Dodecyne	1.723	C₁₂H₂₂	166.172
15.	23.788	13-Tetradece-11-yn-1-ol	3.115	C₁₄H₂₄O	208.182
16.	25.104	Cyclopropanecarboxylic acid, dodec-9-ynyl ester	1.366	C₁₆H₂₆O₂	250.193
Note: Compounds were presented above based on their retention time (minute).

The results from the GCMS analysis of the active fraction revealed the presence of fatty acid esters and monoterpenes, compounds which show active antioxidation (52, 53, 29, 54). The above-mentioned compounds in the extract and active fractions, maybe responsible for the observed antiplasmodial activities in this study.

Fever is one of the cardinal symptoms of malaria especially in humans. However, P. berghei infection in mice is reported to be associated with hypothermia rather than pyrexia (55). Results of rectal temperatures of the infected mice in this study (curative test), showed that there was no significant difference between the mean temperature values of both the treated and untreated infected mice before and after treatment, suggesting that the mice were hypothermic. This hypothermia in mice may have resulted from the serious physiological effects of the malaria parasite on the host, leading to body heat loss and ultimately death of mice (56).["Figure", "https://etflin.com/file/figure/202602230438071510107362.png", "Figure 3. GCMS spectra for methanol fraction.", "", "100%", "1"]["Figure", "https://etflin.com/file/figure/202602230438071296630598.jpeg", "Figure 4. Some identified phytochemicals in methanol GC-MS of T. occidentalis seed extract.", "", "100%", "1"]Consequently, carbohydrate, lipid, and protein metabolisms of the host are affected negatively by malaria parasite (57, 58). Decreases in metabolic rates of the P. berghei-infected mice have been correlated with decreased body temperatures of mice (59). The extract/fractions however, were unable to attenuate these processes and hence the resultant hypothermia.

Conclusion

The findings of this study further suggest that seed extract and fractions of T. occidentalis possess antimalarial potentials which is due to the activities of its phytochemical constituents especially the polyunsaturated fatty acids among others. This confirms and authenticates its use as malarial remedy in folkloric medicine.

Search Results